239
Views
3
CrossRef citations to date
0
Altmetric
Original Research

“I Wish to Continue Receiving the Reminder Short Messaging Service”: A Mixed Methods Study on the Acceptability of Digital Adherence Tools Among Adults Living with HIV on Antiretroviral Treatment in Tanzania

ORCID Icon, ORCID Icon, ORCID Icon, , , , & ORCID Icon show all
Pages 559-568 | Published online: 09 Mar 2021

References

  • UNAIDS. AIDSinfo [Internet]. aidsinfo; 2019. Available from: http://aidsinfo.unaids.org/. Accessed February 24, 2021.
  • Burgoyne AD, Drummond PD. Knowledge of HIV and AIDS in women in sub-Saharan Africa. Afr J Reprod Health. 2008;12(2):14–31.
  • Paterson DL, Swindells S, Mohr J, et al. Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Ann Intern Med. 2000;133(1):21–30. doi:10.7326/0003-4819-133-1-200007040-00004
  • Bangsberg DR, Hecht FM, Charlebois ED, et al. Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS. 2000;14(4):357–366. doi:10.1097/00002030-200003100-00008
  • Lyimo R, van den Boogaard J, Msoka E, et al. Measuring adherence to antiretroviral therapy in northern Tanzania: feasibility and acceptability of the Medication Even Monitoring System. BMC Public Health. 2001;11(92):254.
  • Coetzee B, Kagee A, Vermeulen N. Structural barriers to adherence to antiretroviral therapy in a resource-constrained setting: the perspectives of health care providers. AIDS Care. 2011;23(2):146–151. doi:10.1080/09540121.2010.498874
  • African Strategies for Health. Trends in Digital Health in Africa: lessons From the African Strategies for Health Project; 2016. Available from: http://www.africanstrategies4health.org/uploads/1/3/5/3/13538666/trends_in_digital_health_in_africa_brief_final.pdf. Accessed February 24, 2021.
  • Haberer JE, Kahane J, Kigozi I, et al. Real-time adherence monitoring for HIV antiretroviral therapy. AIDS Behav. 2010;14(6):1340–1346. doi:10.1007/s10461-010-9799-4
  • Pintye J, Rogers Z, Kinuthia J, et al. Two-way short message service (SMS) communication may increase pre-exposure prophylaxis continuation and adherence among pregnant and postpartum women in Kenya. Glob Heal Sci Pract. 2020;8(1):55–67. doi:10.9745/GHSP-D-19-00347
  • Sarna A, Saraswati LR, Okal J, et al. Cell phone counseling improves retention of mothers with HIV infection in care and infant HIV testing in Kisumu, Kenya: a randomized controlled study. Glob Heal Sci Pract. 2019;7(2):171–188. doi:10.9745/GHSP-D-18-00241
  • Evans C, Turner K, Suggs LS, Occa A, Juma A, Blake H. Developing a mHealth intervention to promote uptake of HIV testing among African communities in the conditions: a qualitative study. BMC Public Health. 2016;16(1):1–16. doi:10.1186/s12889-016-3278-4
  • Georgette N, Siedner MJ, Petty CR, Zanoni BC, Carpenter S, Haberer JE. Impact of a clinical program using weekly Short Message Service (SMS) on antiretroviral therapy adherence support in South Africa: a retrospective cohort study. BMC Med Inform Decis Mak. 2017;17(1):1–9. doi:10.1186/s12911-017-0413-9
  • Talisuna AO, Oburu A, Githinji S, et al. Efficacy of text-message reminders on paediatric malaria treatment adherence and their post-treatment return to health facilities in Kenya: a randomized controlled trial ISRCTN39512726 ISRCTN. Malar J. 2017;16(1):1–11. doi:10.1186/s12936-017-1702-6
  • Haberer JE, Musiimenta A, Atukunda EC, et al. Short message service (SMS) reminders and real-time adherence monitoring improve antiretroviral therapy adherence in rural Uganda. Aids. 2016;30(8):1295–1299. doi:10.1097/QAD.0000000000001021
  • Bionghi N, Daftary A, Maharaj B, et al. Pilot evaluation of a second-generation electronic pill box for adherence to Bedaquiline and antiretroviral therapy in drug-resistant TB/HIV co-infected patients in KwaZulu-Natal, South Africa. BMC Infect Dis. 2018;18(1):1–9. doi:10.1186/s12879-018-3080-2
  • Kebaetse MB, Phologolo T. The use of mobile devices in HIV and AIDS communication: opportunities for Botswana. Pula Botswana J African Stud. 2016;30(2):298–311.
  • Ngowi KM, Lyamuya F, Mmbaga B, et al. Technical and Psychosocial challenges of mobile health usage for antiretroviral therapy (ART) adherence among People living with HIV in a resource limited setting: case series. JMIR Form Res. 2019;4:1–9.
  • Mbuagbaw L, Thabane L, Ongolo-Zogo P, et al. The Cameroon Mobile Phone SMS (CAMPS) trial: a randomized trial of text messaging versus usual care for adherence to antiretroviral therapy. PLoS One. 2012;7(12):6–12. doi:10.1371/journal.pone.0046909
  • Reid MJA, Dhar SI, Cary M, et al. Opinions and attitudes of participants in a randomized controlled trial examining the efficacy of SMS reminders to enhance antiretroviral adherence: a cross-sectional survey. J Acquir Immune Defic Syndr. 2014;65(2):1–6. doi:10.1097/QAI.0b013e3182a9c72b
  • Mirambo MM, Sciences A, Kidenya BR, et al. Reduction of HIV transmission rates from mother to child in the era of antiretroviral therapy in the lake victoria zone, tanzania. 2015.
  • Van Der Kop ML, Ojakaa DI, Patel A, et al. The effect of weekly short message service communication on patient retention in care in the first year after HIV diagnosis: study protocol for a randomised controlled trial (WelTel Retain). BMJ Open. 2013;3(6):1–10. doi:10.1136/bmjopen-2013-003155
  • Sekhon M, Cartwright M, Francis JJ. Acceptability of healthcare interventions: an overview of reviews and development of a theoretical framework. BMC Health Serv Res. 2017;17(1):1–13. doi:10.1186/s12913-017-2031-8
  • de Boer IMS, Ngowi KM, Pima FM, et al. Effect of Digital Adherence Tools on adherence to antiretroviral treatment among adults living with HIV in Kilimanjaro, Tanzania: a randomized controlled trial. Manuscr Submitt Publ. 2020.
  • Wisepill. Wisepill RT2000 [Internet]; 2020. Available from: https://www.wisepill.com/. Accessed February 24, 2021.
  • van der Kop ML, Muhula S, Nagide PI, et al. Effect of an interactive text-messaging service on patient retention during the first year of HIV care in Kenya (WelTel Retain): an open-label, randomised parallel-group study. Lancet Public Heal. 2018;3(3):e143–52. doi:10.1016/S2468-2667(17)30239-6
  • Prochaska JO, Velicer WF. The transtheoretical model of health behavior change. Am J Heal Promot. 1997;12(1):38–48. doi:10.4278/0890-1171-12.1.38
  • Muiruri C, Jazowski SA, Semvua SK, et al. Does antiretroviral therapy packaging matter? Perceptions and preferences of antiretroviral therapy packaging for people living with HIV in northern Tanzania. Patient Prefer Adherence. 2020;14:153–161. doi:10.2147/PPA.S238759
  • Langford R. Qualitative research methods, by Monique Hennink, Inge Hutter and Ajay Bailey. Crit Public Health. 2012;22:111–112. doi:10.1080/09581596.2011.565689
  • Ngowi KM, Maro E, Nieuwkerk PT, Aarnoutse RE. User experience of SMS reminders to take medication among pregnant and breastfeeding women living with HIV in Kilimanjaro, Tanzania. BMJGH. 2019;4(Suppl 3):A1–A68.
  • Ronen K, Unger JA, Drake AL, et al. SMS messaging to improve ART adherence: perspectives of pregnant HIV-infected women in Kenya on HIV-related message content. AIDS Care. 2018;30(4):500–505. doi:10.1080/09540121.2017.1417971
  • de Sumari-de Boer IM, van den Boogaard J, Ngowi KM, et al. Feasibility of real time medication monitoring among HIV Infected and TB patients in a resource-limited setting. AIDS Behav. 2016;20(5):1097–1107. doi:10.1007/s10461-015-1254-0
  • Drake AL, Unger JA, Ronen K, et al. Evaluation of mHealth strategies to optimize adherence and efficacy of Option B plus prevention of mother-to-child HIV transmission: rationale, design and methods of a 3-armed randomized controlled trial. Contemp Clin Trials. 2017;57:44–50. doi:10.1016/j.cct.2017.03.007
  • Thiese MS. Observational and interventional study design types; an overview. Biochem Medica. 2014;24(2):199–210. doi:10.11613/BM.2014.022
  • Montgomery ET, Mensch B, Musara P, et al. Misreporting of product adherence in the MTN-003/VOICE Trial for HIV prevention in africa: participants’ explanations for dishonesty. AIDS Behav. 2017;21(2):481–491. doi:10.1007/s10461-016-1609-1
  • Corneli AL, McKenna K, Perry B, et al. The science of being a study participant: FEM-PrEP participants’ explanations for overreporting adherence to the study pills and for the whereabouts of unused pills. JAIDS J Acquir Immune Defic Syndr. 2015;68(5):578.
  • Browne S, Kechadi MT, O’Donnell S, et al. Mobile health apps in pediatric obesity treatment: process outcomes from a feasibility study of a multicomponent intervention. JMIR mHealth uHealth. 2020;8(7):e16925. doi:10.2196/16925